AU2869100A - Storage stable amoxycillin and clavulanate suspension composition - Google Patents
Storage stable amoxycillin and clavulanate suspension compositionInfo
- Publication number
- AU2869100A AU2869100A AU28691/00A AU2869100A AU2869100A AU 2869100 A AU2869100 A AU 2869100A AU 28691/00 A AU28691/00 A AU 28691/00A AU 2869100 A AU2869100 A AU 2869100A AU 2869100 A AU2869100 A AU 2869100A
- Authority
- AU
- Australia
- Prior art keywords
- amoxycillin
- clavulanate
- storage stable
- suspension composition
- suspension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE19990159A IE990159A1 (en) | 1999-02-26 | 1999-02-26 | Storage Stable Amoxycillin and Clavulanate Suspension Composition. |
IE990159 | 1999-02-26 | ||
US09304785 | 1999-04-05 | ||
US09/304,785 US6066629A (en) | 1999-02-26 | 1999-05-04 | Storage stable amoxycillin and clavulanate suspension composition |
PCT/US2000/002856 WO2000050036A1 (en) | 1999-02-26 | 2000-02-03 | Storage stable amoxycillin and clavulanate suspension composition |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2869100A true AU2869100A (en) | 2000-09-14 |
Family
ID=26320240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28691/00A Abandoned AU2869100A (en) | 1999-02-26 | 2000-02-03 | Storage stable amoxycillin and clavulanate suspension composition |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2869100A (en) |
WO (1) | WO2000050036A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006007830A1 (en) * | 2006-02-17 | 2007-08-30 | Grünenthal GmbH | Storage-stable oral dosage form of amoxicillin and clavulanic acid |
TR201000686A1 (en) * | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Water-soluble cefdinir and clavulanic acid formulations for the treatment of bacterial infections. |
TR201000687A1 (en) * | 2010-01-29 | 2011-08-22 | Bi̇lgi̇ç Mahmut | Effervescent formulations containing cefixime and clavulanic acid as active ingredient |
CN112089693B (en) * | 2020-09-28 | 2023-07-28 | 成都倍特药业股份有限公司 | Penicillin composition for injection and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1532993A (en) * | 1975-03-07 | 1978-11-22 | Beecham Group Ltd | Injectable antibiotic compositions |
GB2098236B (en) * | 1981-05-11 | 1984-07-18 | Tate & Lyle Plc | Immobilized enzymes |
US5114929A (en) * | 1989-03-21 | 1992-05-19 | Beecham Group P.L.C. | Pharmaceutical formulation |
JP2001512451A (en) * | 1997-02-14 | 2001-08-21 | スミスクライン・ビーチャム・ラボラトワール・ファルマソーティク | Pharmaceutical formulations containing amoxicillin and clavulanate |
-
2000
- 2000-02-03 AU AU28691/00A patent/AU2869100A/en not_active Abandoned
- 2000-02-03 WO PCT/US2000/002856 patent/WO2000050036A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000050036A1 (en) | 2000-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4570600A (en) | Storage media | |
AU4520801A (en) | Novel substituted phenanthridinones and methods of use thereof | |
AU2466099A (en) | Pharmaceutically active compounds and methods of use thereof | |
AU7989400A (en) | Compounds and methods | |
AU3215500A (en) | Compounds and methods | |
IL131201A (en) | Pharmaceutical formulations comprising amoxycillin and clavulanate | |
AU4923200A (en) | Isothiazolecarboxamides and their use as microbicides | |
AU5814096A (en) | Composition comprising amoxycillin and clavulanic acid | |
AU1403501A (en) | Novel composition and use | |
HUP0103015A3 (en) | Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose | |
AU3931400A (en) | N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators | |
AU1766997A (en) | Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors | |
AU5093900A (en) | Storage of beverages | |
AU1152601A (en) | Compositions and their use | |
AU2869100A (en) | Storage stable amoxycillin and clavulanate suspension composition | |
AU5050198A (en) | Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors | |
AU4276496A (en) | 3-Thioheteroaryl cephalosporin compounds, compositions and methods of use | |
AU4129800A (en) | Bis-benzazoles and their use as antineoplastic agents | |
AU2529501A (en) | Macrocyclic compounds and their use | |
AU1314601A (en) | Implements and methods of manufacturing same | |
AU2152497A (en) | Heterocyclic compounds and their preparation and use | |
AU2205401A (en) | Pharmaceutical formulations comprising sodium amoxycillin and potassium clavulanate | |
AU6204400A (en) | Novel kinases and uses thereof | |
AU8035098A (en) | Cephalosporin compounds, use thereof and intermediate compounds of the same | |
AU1232500A (en) | Improved amoxycillin and clavulanate composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |